Beauty & aesthetics
AIAI-generated summary. The stories on this topic, newest first.
Galderma has signed an agreement to acquire US physician-dispensed skincare brand ZO Skin Health for $1.5 billion, deepening its dermatological skincare portfolio and its position in medical aesthetics.
Why it matters It consolidates the physician-dispensed skincare channel, a fast-growing slice of premium skin care.
Earlier on this storyGalderma to buy ZO Skin Health for $1.5bn
Sean Harrington, who co-founded Elemis and spent 37 years with the brand, has joined investment bank Lempriere Wells as partner to support its push into the US beauty, wellness and longevity markets.
Why it matters It signals that dealmaking appetite in beauty and wellness keeps pulling experienced operators into advisory roles.
Galderma has signed an agreement to acquire physician-dispensed brand ZO Skin Health for $1.5 billion, a deal that could close as early as the fourth quarter of 2026. The purchase deepens Galderma's position in medical-grade dermatological skin care.
Why it matters It is the largest consolidation move reported today in the fast-growing medical-grade skin care segment.
L'Oréal Travel Retail and travel retailer Avolta have signed a joint Sustainability-Linked Business Plan to scale refillable fragrance formats, cut supply chain emissions and expand circular solutions. The plan targets refillable formats accounting for 10 percent of fragrance solutions at travel hubs by 2030.
Why it matters Duty-free is a high-volume channel for fragrance, so refill commitments there carry real weight for packaging and waste goals.
LVMH reported a 1 percent rise in organic revenue for the third quarter of 2026, helped by its Perfumes & Cosmetics and Selective Retailing divisions, with Sephora growing across geographies and lines such as Rhode entering European stores. Demand in China remained weaker.
Why it matters LVMH is the sector's biggest bellwether, and its beauty and retail divisions are holding up even as Chinese demand softens.
Givaudan reported better-than-expected revenue for January to September 2026, driven by its fine fragrances business, and its stock surged. Rival Symrise opened a new scent center in Singapore.
Why it matters Fine fragrance is the strongest corner of the beauty supply chain right now, and the two biggest suppliers are investing to keep pace.